Source: Virtual Congress 2021 – COVID - 19: lessons learned



Rating:

Share or cite this content

Citations should be made in the following way:
S. Maazaoui (Tunis, Tunisia), a. chaieb (Tunis, Tunisia), S. Habibech (Tunis, Tunisia), T. Zneigui (Tunis, Tunisia), M. Friha (Tunis, Tunisia), S. Ghdira (Tunis, Tunisia), N. Mefteh (Tunis, Tunisia), H. Racil (Tunis, Tunisia), N. Chaouch (Tunis, Tunisia). Anosmia and ageusia good prognosis factors of COVID-19?. 520

Member's Comments

No comment yet.

Related content which might interest you: Williams-Campbell syndrome: is an infantile rare disease with poor prognosis? Source: Annual Congress 2008 - Rare clinical cases Year: 2008 Obesity in patients with COVID-19: is it a predictive factor for a poor prognosis? Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021 Early bedside clinical prediction of deterioration in COVID-19 happy hypoxaemic phenotype associated with good prognosis. Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 What are the risk factors for a bad outcome of work-related asthma? Source: Annual Congress 2011 - New ERS Guidelines: Management of Work-Related Asthma Year: 2011 Multimorbidity medications and poor asthma prognosis Source: Eur Respir J, 51 (4) 1702114; 10.1183/13993003.02114-2017 Year: 2018 Prognostic factors after successful embolization for life-threatening hemoptysis Source: Annual Congress 2005 - Information for the active clinician Year: 2005 Alpha-1-antitrypsine dephiciency. Can we improve prognosis? Source: Annual Congress 2008 - Pulmonary infections in children - rare but important aspects Year: 2008 Do prognostic factors help physicians in predicting legionellosis‘ respiratory complications? Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011 Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis? Source: Eur Respir J 2016; 48: 279-281 Year: 2016 Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis? Source: Eur Respir J 2016; 48: 281-282 Year: 2016 Etiology and prognosis factors in severe community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 477s Year: 2002 Bronchiectasis surgery: indications and risk factors? Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Is asthma a risk factor for severe outcomes in COVID 19? Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials Year: 2021 Sarcoidosis treatment and outcomes: what is most important to patients? Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Fever – risk factor for recurrent wheeze in early life? Source: Eur Respir J 2004; 24: Suppl. 48, 167s Year: 2004 Prognosis in COPD. Ignorance is bliss? Source: Eur Respir J 2002; 20: Suppl. 38, 264s Year: 2002 Atopic cystic fibrosis patients: a poorer prognosis? Source: Eur Respir J 2007; 30: Suppl. 51, 386s Year: 2007 Atopy in sarcoidosis a good prognostic sign? Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Is there hope of improving the prognosis of pulmonary tumour thrombotic microangiopathy? Source: Eur Respir J 2016; 47: 688-690 Year: 2016